StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Exicure's total debt was $1.00M at Jun 30, 2024. For fiscal 2023 it was $0. The highest annual figure on record is $16.59M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$6.87M-58.6%
FY2020Dec 31, 2020$16.59M+234.1%
FY2019Dec 31, 2019$4.97M+0.8%
FY2018Dec 31, 2018$4.93M+1.4%
FY2017Dec 31, 2017$4.86M-14.3%
FY2016Dec 31, 2016$5.67M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024$1.00M–
Q4 FY2023Dec 31, 2023$0–
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$0-100.0%
Q4 FY2021Dec 31, 2021$6.87M-58.6%
Q3 FY2021Sep 30, 2021$16.80M+1.8%
Q2 FY2021Jun 30, 2021$16.73M–
Q1 FY2021Mar 31, 2021$16.66M–
Q4 FY2020Dec 31, 2020$16.59M+234.1%
Q3 FY2020Sep 30, 2020$16.50M+235.9%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$4.97M+0.8%
Q3 FY2019Sep 30, 2019$4.91M-0.3%
Q2 FY2019Jun 30, 2019$4.86M-0.9%
Q1 FY2019Mar 31, 2019$4.81M-1.5%
Q4 FY2018Dec 31, 2018$4.93M+1.4%
Q3 FY2018Sep 30, 2018$4.93M-5.7%
Q2 FY2018Jun 30, 2018$4.90M-13.5%
Q1 FY2018Mar 31, 2018$4.88M–
Q4 FY2017Dec 31, 2017$4.86M–
Q3 FY2017Sep 30, 2017$5.22M–
Q4 FY2016Dec 31, 2016$5.67M–

More Exicure figures

See a number that looks wrong?